TriptoBIO is developing a biotechnology platform that utilizes synthetic biology techniques to produce natural plant compounds at scale. This approach addresses the challenge of sourcing sustainable and cost-effective bioactive ingredients for various industries, including pharmaceuticals and cosmetics.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Sourcing natural plant compounds for pharmaceuticals, cosmetics, and other industries often relies on traditional farming and petrochemicals, leading to unsustainable practices and environmental impact. Rare compounds, like those found in *Tripterygium wilfordii*, are difficult to obtain in large quantities through plant harvesting.
Solution
TriptoBIO is developing a biotechnology platform that uses synthetic biology and fermentation to produce di- and tetraterpenoids, enabling the sustainable production of natural plant compounds at scale. This approach reduces the need for traditional farming and petrochemicals, offering a more environmentally friendly solution for accessing bioactive ingredients. Their initial focus is on producing compounds that can be used for safe, non-toxic pest control, specifically targeting rat populations. The platform aims to provide sustainable solutions that benefit various industries without depleting natural resources.
Target Audience
The primary target audience includes companies in the pharmaceutical, cosmetic, and agricultural industries seeking sustainable and scalable sources of natural plant compounds.
Features
- Production of di- and tetraterpenoids through fermentation
- Sustainable sourcing of rare diterpenoids, such as those found in *Tripterygium wilfordii*
- Alternative to traditional farming and petrochemical-based production methods
- Focus on developing compounds for safe, non-toxic pest control